Correlation Between Pfizer and INVO Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and INVO Bioscience, you can compare the effects of market volatilities on Pfizer and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and INVO Bioscience.

Diversification Opportunities for Pfizer and INVO Bioscience

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and INVO is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of Pfizer i.e., Pfizer and INVO Bioscience go up and down completely randomly.

Pair Corralation between Pfizer and INVO Bioscience

Considering the 90-day investment horizon Pfizer is expected to generate 33.13 times less return on investment than INVO Bioscience. But when comparing it to its historical volatility, Pfizer Inc is 8.58 times less risky than INVO Bioscience. It trades about 0.01 of its potential returns per unit of risk. INVO Bioscience is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  90.00  in INVO Bioscience on October 7, 2024 and sell it today you would lose (18.00) from holding INVO Bioscience or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.92%
ValuesDaily Returns

Pfizer Inc  vs.  INVO Bioscience

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
INVO Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days INVO Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and INVO Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and INVO Bioscience

The main advantage of trading using opposite Pfizer and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.
The idea behind Pfizer Inc and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance